Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Dyadic International Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 36 | 34 | −2 |
| Shares | 3.83M | 3.81M | −22.3K (−0.6%) |
| Value | $17.3M | $11.5M | −$5.85M (−33.8%) |
New holders (3)
Institutions that held Dyadic International Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Captrust Financial Advisors | 15,000 | $45.0K | 0.00% |
| Citadel Advisors LLC | 14,563 | $44.0K | 0.00% |
| UBS Group AG | 2,294 | $7.00K | 0.00% |
Sold out (5)
Institutions that held Dyadic International Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Trexquant Investment LP | 30,526 | $138.0K |
| Equitable Holdings, Inc. | 19,250 | $87.0K |
| Wolverine Trading, LLC | 10,983 | $48.0K |
| Patriot Financial Group Insurance Agency, LLC | 125 | $1.00K |
| FMR LLC | 4 | $0 |